SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-034995
Filing Date
2020-03-18
Accepted
2020-03-18 08:00:49
Documents
12
Period of Report
2020-03-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012926d1_8k.htm   iXBRL 8-K 24955
  Complete submission text file 0001104659-20-034995.txt   199317

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA espr-20200314.xsd EX-101.SCH 3186
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20200314_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20200314_pre.xml EX-101.PRE 22710
13 EXTRACTED XBRL INSTANCE DOCUMENT tm2012926d1_8k_htm.xml XML 3625
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 20723206
SIC: 2834 Pharmaceutical Preparations